Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 10, 2023 21:15 ET | Source: Global Market Insights Inc.

Prostate Cancer Diagnostics Market to hit USD 11.5 billion by 2032, says Global Market Insights Inc.

Selbyville, Delaware, Sept. 10, 2023 (GLOBE NEWSWIRE) -- Prostate Cancer Diagnostics Market size is anticipated to be worth more than USD 11.5 billion in revenue by 2032. The burgeoning burden of...
October 13, 2019 19:00 ET | Source: Telix Pharmaceuticals Limited

Telix Pharmaceuticals and GE Healthcare: Maximising 68Ga Supply for Prostate Cancer Imaging

MELBOURNE, Australia, Oct. 14, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX, “Telix”, the “Company”) a clinical-stage biopharmaceutical company focused on the development of...
January 23, 2019 08:00 ET | Source: Telix Pharmaceuticals Limited

Telix Pharmaceuticals Launches illumet™ Microsite (Kit for the Preparation of 68Ga-PSMA)

MELBOURNE, Australia and INDIANAPOLIS, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix Group”, “Company”), a clinical-stage biopharmaceutical company focused on the...
November 26, 2018 02:00 ET | Source: Telix Pharmaceuticals Limited

Telix Pharmaceuticals Acquires Advanced Nuclear Medicine Ingredients (ANMI) SA

MELBOURNE, Australia, BRUSSELS and LIÈGE, Belgium, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company...
October 14, 2018 18:00 ET | Source: Telix Pharmaceuticals Limited

Telix and ANMI Expand PSMA Imaging Partnership

MELBOURNE, Australia and LIÈGE, Belgium, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...
October 02, 2018 20:00 ET | Source: Telix Pharmaceuticals Limited

Telix Pharmaceuticals and Cardinal Health Enter into Distribution Agreement for Prostate Cancer Imaging

INDIANAPOLIS and COLUMBUS, Ohio, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals (US) Inc. (“Telix USA”), a subsidiary of Telix Pharmaceuticals Limited (ASX:TLX), a clinical-stage...
August 12, 2018 18:00 ET | Source: Telix Pharmaceuticals Limited

First Patient Imaged in Prostate Imaging Study

MELBOURNE, Australia, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of...